IGC Pharma Inc (IGC)
0.5104
-0.01
(-1.85%)
USD |
NYAM |
May 10, 16:00
0.5104
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Profit Margin (Quarterly): -2.74K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.74K% |
| September 30, 2023 | -842.3% |
| June 30, 2023 | -373.9% |
| March 31, 2023 | -2.43K% |
| December 31, 2022 | -677.4% |
| September 30, 2022 | -1.21K% |
| June 30, 2022 | -1.31K% |
| March 31, 2022 | -5.33K% |
| December 31, 2021 | -1.68K% |
| September 30, 2021 | -7.76K% |
| June 30, 2021 | -2.32K% |
| March 31, 2021 | -3.64K% |
| December 31, 2020 | -2.15K% |
| September 30, 2020 | -1.33K% |
| June 30, 2020 | -322.3% |
| March 31, 2020 | -10.88K% |
| December 31, 2019 | -279.8% |
| September 30, 2019 | -64.74% |
| June 30, 2019 | -83.63% |
| March 31, 2019 | -102.3% |
| December 31, 2018 | -89.34% |
| September 30, 2018 | -105.9% |
| June 30, 2018 | -34.64% |
| March 31, 2018 | -50.35% |
| December 31, 2017 | -69.95% |
| Date | Value |
|---|---|
| September 30, 2017 | -129.4% |
| June 30, 2017 | -816.5% |
| March 31, 2017 | -814.6% |
| December 31, 2016 | -44.66% |
| September 30, 2016 | -360.1% |
| June 30, 2016 | -133.0% |
| March 31, 2016 | -104.1% |
| December 31, 2015 | -37.14% |
| September 30, 2015 | -30.33% |
| June 30, 2015 | -20.59% |
| March 31, 2015 | -85.03% |
| December 31, 2014 | -23.21% |
| September 30, 2014 | -41.90% |
| June 30, 2014 | -157.3% |
| March 31, 2014 | |
| December 31, 2013 | -1.77K% |
| September 30, 2013 | -54.27% |
| June 30, 2013 | -56.36% |
| March 31, 2013 | -128.1% |
| December 31, 2012 | 7.90% |
| September 30, 2012 | -10.56% |
| June 30, 2012 | -41.68% |
| March 31, 2012 | -338.0% |
| December 31, 2011 | -192.7% |
| September 30, 2011 | -86.53% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.88K%
Minimum
Mar 2020
-64.74%
Maximum
Sep 2019
-2.39K%
Average
-1.33K%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |
| Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -101.6% |
| Return on Assets | -87.65% |
| Return on Invested Capital | -100.6% |
| Gross Profit Margin (Quarterly) | 65.20% |
| Operating Margin (Quarterly) | -1.47K% |
| Return on Net Operating Assets | -118.0% |